Cassava Sciences, Inc. (SAVA) DCF Valuation

Cassava Sciences, Inc. (SAVA) Valoración de DCF

US | Healthcare | Biotechnology | NASDAQ
Cassava Sciences, Inc. (SAVA) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Cassava Sciences, Inc. (SAVA) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Ingementada para su precisión, nuestra calculadora DCF (SAVA) le permite evaluar la valoración de Cassava Sciences, Inc. con datos financieros del mundo real y una flexibilidad completa para modificar todos los parámetros esenciales para mejorar las proyecciones.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 -100 -25 -25 -25 -25 -25
EBITDA -4.6 -6.3 -31.9 -74.9 -95.7 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 4163611.11 100 100 100 100 100 100
Depreciation .1 .0 .5 1.3 1.5 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 -72277.78 100 60 60 60 60 60
EBIT -4.6 -6.3 -32.4 -76.2 -97.2 .0 .0 .0 .0 .0
EBIT, % 100 100 100 4235888.89 100 100 100 100 100 100
Total Cash 23.1 93.5 233.4 201.0 121.1 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 -11.2 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 1.0
Account Receivables, % 100 100 100 0 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 0 100 80 80 80 80 80
Accounts Payable .5 .9 7.1 4.0 10.6 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 -223166.67 100 60 60 60 60 60
Capital Expenditure .0 .0 -22.2 -2.7 -.4 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 150666.67 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -4.2 -5.9 -31.8 -72.5 -97.2 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -3.8 -5.4 -47.3 -77.0 -90.5 -9.6 .0 .0 .0 .0
WACC, % 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39
PV UFCF
SUM PV UFCF -9.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -9
Net Debt -121
Equity Value 112
Diluted Shares Outstanding, MM 42
Equity Value Per Share 2.67

What You Will Get

  • Real SAVA Financial Data: Pre-filled with Cassava Sciences' historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Cassava Sciences' intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Cassava Sciences, Inc. (SAVA).
  • WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to SAVA.
  • Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates as needed.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios for Cassava Sciences, Inc. (SAVA).
  • Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Cassava Sciences data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Cassava Sciences’ intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Cassava Sciences, Inc. (SAVA)?

  • Accurate Data: Real Cassava Sciences financials provide dependable valuation outcomes.
  • Customizable: Modify key metrics such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-built calculations save you from starting from the ground up.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Intuitive design and step-by-step guidance make it accessible for all users.

Who Should Use This Product?

  • Biotech Students: Explore drug development processes and apply theoretical knowledge using real-world data.
  • Researchers: Integrate innovative models into studies focusing on neurodegenerative diseases.
  • Investors: Evaluate your own hypotheses and assess valuation metrics for Cassava Sciences, Inc. (SAVA).
  • Market Analysts: Enhance your analysis with a customizable financial model tailored for biotech companies.
  • Healthcare Professionals: Understand how public biotech firms like Cassava Sciences are evaluated in the market.

What the Template Contains

  • Historical Data: Includes Cassava Sciences, Inc. (SAVA)’s past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Cassava Sciences, Inc. (SAVA)’s intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Cassava Sciences, Inc. (SAVA)’s financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.